Terms: = Liver cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
5 results:
1. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform cancer Therapy.
Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
[TBL] [Abstract] [Full Text] [Related]
2. foxa1
Liang J; Tian C; Zeng Y; Yang Q; Liu Y; Liu Y; Wu J; Hu Y; Gu F; Zhang K; Wang Y; Zhang Y; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(1):308-315. PubMed ID: 31036318
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras
Vilimas T; Wang AQ; Patnaik S; Hughes EA; Singleton MD; Knotts Z; Li D; Frankowski K; Schlomer JJ; Guerin TM; Springer S; Drennan C; Dextras C; Wang C; Gilbert D; Southall N; Ferrer M; Huang S; Kozlov S; Marugan J; Xu X; Rudloff U
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1067-1080. PubMed ID: 30306263
[TBL] [Abstract] [Full Text] [Related]
4. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
Bianco S; Jangal M; Garneau D; Gévry N
Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
[TBL] [Abstract] [Full Text] [Related]
5. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract] [Full Text] [Related]
